Literature DB >> 176427

Anatomy of herpes simplex virus DNA. V. Terminally repetitive sequences.

S Wadsworth, G S Hayward, B Roizman.   

Abstract

Native DNA from four strains of herpes simplex virus 1 (HSV-1) circularized after digestion with the lambda exonuclease, indicating that the molecules were terminally repetitious. In two strains, the terminal repetition was evident in nearly 50% of the DNA molecules. Maximal circularization was observed when only 0.25 to 0.5% of the DNA was depolymerized by the exonuclease, suggesting that the minimal size of the terminally repetitious regions is in the range of 400 to 800 bases pairs. More extensive exonuclease treatment resulted in a reduction in the frequency of circularization. To determine whether the terminally repetitive regions themselves contained self-annealing sequences that were precluding circularization of more extensively digested DNA, the terminal fragments from HinIII restriction endonuclease digests were isolated, denatured, and tested for their ability to self-anneal. The results of hydroxyapatite column chromatography and electron microscope examination of the terminal regions are consistent with this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 176427      PMCID: PMC515442     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  11 in total

1.  Terminal repetitions in herpes simplex virus type 1 DNA.

Authors:  R H Grafstrom; J C Alwine; W L Steinhart; C W Hill
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  The terminal repetition of herpes simplex virus DNA.

Authors:  R H Grafstrom; J C Alwine; W L Steinhart; C W Hill; R W Hyman
Journal:  Virology       Date:  1975-09       Impact factor: 3.616

3.  Inverted repetitions in the chromosome of herpes simplex virus.

Authors:  P Sheldrick; N Berthelot
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

4.  Anatomy of herpes simplex virus DNA: strain differences and heterogeneity in the locations of restriction endonuclease cleavage sites.

Authors:  G S Hayward; N Frenkel; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

5.  Anatomy of herpes simplex virus DNA. III. Characterization of defective DNA molecules and biological properties of virus populations containing them.

Authors:  N Frenkel; R J Jacob; R W Honess; G S Hayward; H Locker; B Roizman
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

6.  Anatomy of herpes simplex virus DNA. II. Size, composition, and arrangement of inverted terminal repetitions.

Authors:  S Wadsworth; R J Jacob; B Roizman
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

7.  Defective virions of herpes simplex viruses.

Authors:  D L Bronson; G R Dreesman; N Biswal; M Benyesh-Melnick
Journal:  Intervirology       Date:  1973       Impact factor: 1.763

8.  Preparation of herpes simplex virus of high titer.

Authors:  B Roizman; P G Spear
Journal:  J Virol       Date:  1968-01       Impact factor: 5.103

9.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

10.  Anatomy of herpes simplex virus DNA: evidence for four populations of molecules that differ in the relative orientations of their long and short components.

Authors:  G S Hayward; R J Jacob; S C Wadsworth; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

View more
  38 in total

1.  Characterization of a herpes simplex virus sequence which binds a cellular protein as either a single-stranded or double-stranded DNA or RNA.

Authors:  L McCormick; R J Roller; B Roizman
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  Origin of two different classes of defective HSV-1 Angelotti DNA.

Authors:  H C Kaerner; I B Maichle; A Ott; C H Schröder
Journal:  Nucleic Acids Res       Date:  1979-04       Impact factor: 16.971

3.  Anatomy of herpes simplex virus DNA. XII. Accumulation of head-to-tail concatemers in nuclei of infected cells and their role in the generation of the four isomeric arrangements of viral DNA.

Authors:  R J Jacob; L S Morse; B Roizman
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

4.  Structure of the joint region and the termini of the DNA of herpes simplex virus type 1.

Authors:  M J Wagner; W C Summers
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

5.  DNA of Epstein-Barr virus. II. Comparison of the molecular weights of restriction endonuclease fragments of the DNA of Epstein-Barr virus strains and identification of end fragments of the B95-8 strain.

Authors:  S D Hayward; E Kieff
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

6.  Anatomy of herpes simplex virus DNA VIII. Properties of the replicating DNA.

Authors:  R J Jacob; B Roizman
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

7.  Physical map of the origin of defective DNA in herpes simplex virus type 1 DNA.

Authors:  B J Graham; Z Bengali; G F Vande Woude
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

8.  Analysis of herpes simplex virus type 1 DNA packaging signal mutations in the context of the viral genome.

Authors:  Lily Tong; Nigel D Stow
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

9.  Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle.

Authors:  Shih-Hsin Chiu; Meng-Chuan Wu; Chung-Chun Wu; Yu-Ching Chen; Su-Fang Lin; John T-A Hsu; Chung-Shi Yang; Ching-Hwa Tsai; Kenzo Takada; Mei-Ru Chen; Jen-Yang Chen
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

10.  Fragments from both termini of the herpes simplex virus type 1 genome contain signals required for the encapsidation of viral DNA.

Authors:  N D Stow; E C McMonagle; A J Davison
Journal:  Nucleic Acids Res       Date:  1983-12-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.